Demyelinating Sensorimotor Polyneuropathy Associated With the Use of Sirolimus: A Case Report

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1545-1547

  Bilodeau, M ^a   Hassoun, Z ^a   Brunet, D ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; RAPAMYCIN; STEROID;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANEMIA; ARTICLE; ATAXIA; CASE REPORT; DEMYELINATING NEUROPATHY; DETERIORATION; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; NERVE CONDUCTION; NEUROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; RETRANSPLANTATION; SENSORIMOTOR NEUROPATHY; SKIN TINGLING; TREATMENT INDICATION; WEAKNESS;

ALPHA 1-ANTITRYPSIN DEFICIENCY; CYCLOSPORINE; DEMYELINATING DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYNEUROPATHIES; SIROLIMUS;

EID: 45449085236     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.094     Document Type: Article

References (20)

1. Mueller A.R., Platz K.P., Bechstein W.O., et al. Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 58 (1994) 155
2. Stein D.P., Lederman R.J., Vogt D.P., et al. Neurological complications following liver transplantation. Ann Neurol 31 (1992) 644
3. Ghaus N., Bohlega S., and Rezeig M. Neurological complications in liver transplantation. J Neurol 248 (2001) 1042
4. Lewis M.B., and Howdle P.D. Neurologic complications of liver transplantation in adults. Neurology 61 (2003) 1174
5. Lopez O.L., Estol C., Colina I., et al. Neurologic complications after liver retransplantation. Hepatology 16 (1992) 162
6. Wilson J.R., Conwit R.A., Eidelman B.H., et al. Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nervel 17 (1994) 528
7. Echaniz-Laguna A., Battaglia F., Ellero B., et al. Chronic inflammatory demyelinating polyradiculoneuropathy in patients with liver transplantation. Muscle Nerve 30 (2004) 501
8. Köller H., Schroeter M., Kieseier B.C., et al. Chronic inflammatory demyelinating polyneuropathy-update on pathogenesis, diagnostic criteria and therapy. Curr Opin Neurol 18 (2005) 273
9. Bronster D.J., Yonover P., Stein J., et al. Demyelinating sensorimotor polyneuropathy after administration of FK506. Transplantation 59 (1995) 1066
10. Ponticelli C., and Campise M.R. Neurological complications in kidney transplant recipients. J Nephrol 18 (2005) 521
11. Eidelman B.H., Abu-Elmagd K., Wilson J., et al. Neurologic complications of FK506. Transplant Proc 23 (1991) 3175
12. Appignani B.A., Bhadelia R.A., Blacklow S.C., et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. Am J Roentgenol 166 (1996) 683
13. Taylor B.V., Wijdicks E.F., Poterucha J.J., et al. Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation. Ann Neurol 38 (1995) 828
14. Menegaux F., Keeffe E.B., Andrews B.T., et al. Neurological complications of liver transplantation in adult versus pediatric patients. Transplantation 58 (1994) 447
15. Maramattom B.V., and Wijdicks E.F. Sirolimus may not cause neurotoxicity in kidney and liver transplant recipients. Neurology 63 (2004) 1958
16. Ussetti P., Laporta R., de Pablo A., et al. Rapamycin in lung transplantation: preliminary results. Transplant Proc 35 (2003) 1974
17. Forgacs B., Merhav H.J., Lappin J., et al. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. Transplant Proc 37 (2005) 1912
18. Daoud D., Scheld H.H., Speckmann E.J., et al. Rapamycin: brain excitability studied in vitro. Epilepsia 48 (2007) 834
19. Erlich S., Alexandrovich A., Shohami E., et al. Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26 (2007) 86
20. Bodkin C.L., and Eidelman B.H. Sirolimus-induced posterior reversible encephalopathy. Neurology 68 (2007) 2039